NCT02197598View on ClinicalTrials.gov

Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Conditions
Alcohol Dependence
Interventions
DRUG

nalmefene

Trial Locations (3)

Unknown

DE001, Heidelberg

DE002, Mannheim

Optuminisight, München

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02197598 - Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use | Biotech Hunter | Biotech Hunter